Effect of Hand Massage Stimulation on Pain and Menstrual Symptoms in Primary Dysmenorrhea (NCT07544511) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Effect of Hand Massage Stimulation on Pain and Menstrual Symptoms in Primary Dysmenorrhea
Turkey (Türkiye)60 participantsStarted 2025-09-01
Plain-language summary
Purpose of this study: The purpose of this study is to determine the effect of hand massage stimulation techniques on pain, daily menstrual symptoms and nausea and vomiting in primary dysmenorrhea.
H1a: Hand massage stimulation techniques reduce pain in primary dysmenorrhea. H1b: Hand massage stimulation techniques reduce daily menstrual symptoms in primary dysmenorrhea.
The data were collected from students suffering from primary dysmenorrhea pain studying at İnönü University Faculty of Health Sciences. Seed therapy (su-jok) will be applied by researcher Esra Tan, who has a basic level su-jok therapy certificate.
Who can participate
Age range
18 Years – 50 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participant who is 18 years or older
* Participant diagnosed with primary dysmenorrhea by a gynecologist
* Participant who has had regular menstruation in the last 6 months
* Participant whose menstrual pain continues for 8-72 hours
Exclusion Criteria:
* Participant who is pregnant
* Participant who has given birth before or has a history of pregnancy
* Participant using intrauterine or oral contraceptives
* Participant who is taking any anti-inflammatory, analgesic and psychotherapeutic medication
* Participant with any history of pelvic pathology or pelvic surgery
* Participant with any neurological or systemic disease
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual Analog Scale (VAS)
Timeframe: At baseline (pre-intervention) and immediately after completion of seed therapy]